Population Pharmacokinetic Analysis of Amikacin for Optimal Pharmacotherapy in Korean Patients with Nontuberculous Mycobacterial Pulmonary Disease

MLA

Xuanyou Jin, et al. “Population Pharmacokinetic Analysis of Amikacin for Optimal Pharmacotherapy in Korean Patients with Nontuberculous Mycobacterial Pulmonary Disease.” Antibiotics, vol. 9, no. 11, Nov. 2020, p. 784. EBSCOhost, https://doi.org/10.3390/antibiotics9110784.

APA

Xuanyou Jin, Jaeseong Oh, Joo-Youn Cho, SeungHwan Lee, & Su-jin Rhee. (2020). Population Pharmacokinetic Analysis of Amikacin for Optimal Pharmacotherapy in Korean Patients with Nontuberculous Mycobacterial Pulmonary Disease. Antibiotics, 9(11), 784. https://doi.org/10.3390/antibiotics9110784

Chicago

Xuanyou Jin, Jaeseong Oh, Joo-Youn Cho, SeungHwan Lee, and Su-jin Rhee. 2020. “Population Pharmacokinetic Analysis of Amikacin for Optimal Pharmacotherapy in Korean Patients with Nontuberculous Mycobacterial Pulmonary Disease.” Antibiotics 9 (11): 784. doi:10.3390/antibiotics9110784.